Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Ascertain, based in New York City, focuses on automating healthcare administration using its AI platform. Founded by experts in healthcare and technology, the firm aims to reduce administrative burdens that hinder patient care. Specific fund size and AUM details are not available.
Ascertain invests in technologies that streamline healthcare operations, particularly through automation. They specialize in workflows such as prior authorizations, eligibility verification, claims management, and care coordination. The firm integrates its solutions with existing healthcare systems to enhance operational efficiency and patient access.
Notable partnerships include The Oncology Institute, where Ascertain improved prior authorization workload across over 100 oncology clinics, achieving a 95% faster submission rate. Additionally, with Northwell Health, Ascertain's case management pilot reduced user clicks by 80% and cut authorization submission time by 67%.
Submit your pitch through their website's contact form for consideration.
Ascertain typically leads investment rounds, particularly in early-stage healthcare technology companies.
The firm is open to follow-on investments, especially if the portfolio company demonstrates significant growth and operational improvements.
Ascertain's unique focus on automating healthcare administration through AI sets it apart from other investors in the healthcare sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.